Literature DB >> 28849103

Long non-coding RNAs on the stage of cervical cancer (Review).

Junxue Dong1, Manman Su2, Weiqin Chang1, Kun Zhang1, Shuying Wu1, Tianmin Xu1.   

Abstract

Cervical cancer is one of most malignant gynecological tumors. However, effective means for diagnosing and treating cervical cancer have yet to be identified. A few decades ago, long non-coding RNAs (lncRNAs) were regarded as useless parts of the genome, however, increasing data have demonstrated the importance of lncRNAs in the diagnosis and treatment of cervical cancers. The aim of the present study is to summarize the role(s) of HOTAIR, MALAT1, CCAT2, SPRY4-IT1, RSU1P2, CCHE1, lncRNA-EBIC and PVT1. Approximately 14 lncRNAs are involved in cervical cancer and several important proteins, miRNAs and other molecules and play crucial roles in a few traditional signaling pathways that have been proven to be related to those lncRNAs. In conclusion, lncRNAs may be useful as exact treatment targets and diagnostic biomarkers for improving therapies in cervical cancer patients and lncRNAs may contribute to effective diagnosis and treatment methods for cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28849103     DOI: 10.3892/or.2017.5905

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  27 in total

1.  LINC00313 regulates the metastasis of testicular germ cell tumors through epithelial-mesenchyme transition and immune pathways.

Authors:  Zhizhong Liu; Bairong Fang; Jian Cao; Qianyin Zhou; Fang Zhu; Liqing Fan; Lei Xue; Chuan Huang; Hao Bo
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

2.  Long non-coding RNA HOTAIR promotes cervical cancer progression through regulating BCL2 via targeting miR-143-3p.

Authors:  Mingzhu Liu; Jinying Jia; Xinjie Wang; Yanjie Liu; Chunfang Wang; Ruitai Fan
Journal:  Cancer Biol Ther       Date:  2018-02-06       Impact factor: 4.742

3.  Long non-coding RNA CDKN2B-AS1 promotes osteosarcoma by increasing the expression of MAP3K3 via sponging miR-4458.

Authors:  Daokun Gui; Hanqi Cao
Journal:  In Vitro Cell Dev Biol Anim       Date:  2020-01-16       Impact factor: 2.416

4.  The lncRNA TDRG1 promotes cell proliferation, migration and invasion by targeting miR-326 to regulate MAPK1 expression in cervical cancer.

Authors:  Hui Jiang; Min Liang; Yanqiong Jiang; Ting Zhang; Kexin Mo; Suwen Su; Aiping Wang; Yongyi Zhu; Guanqun Huang; Rujian Zhou
Journal:  Cancer Cell Int       Date:  2019-05-31       Impact factor: 5.722

5.  Long non-coding RNA FAM83H-AS1 is regulated by human papillomavirus 16 E6 independently of p53 in cervical cancer cells.

Authors:  Jamie A Barr; Karen E Hayes; Tayvia Brownmiller; Abby D Harold; Rajaganapathi Jagannathan; Paul R Lockman; Saleem Khan; Ivan Martinez
Journal:  Sci Rep       Date:  2019-03-06       Impact factor: 4.379

6.  Silencing of KCNA1 suppresses the cervical cancer development via mitochondria damage.

Authors:  Li Liu; Yumei Chen; Qingyuan Zhang; Changzhong Li
Journal:  Channels (Austin)       Date:  2019-12       Impact factor: 2.581

Review 7.  The Role of Long Noncoding RNAs in Human Papillomavirus-associated Pathogenesis.

Authors:  Surendra Sharma; Karl Munger
Journal:  Pathogens       Date:  2020-04-15

8.  LncRBase V.2: an updated resource for multispecies lncRNAs and ClinicLSNP hosting genetic variants in lncRNAs for cancer patients.

Authors:  Troyee Das; Aritra Deb; Sibun Parida; Sudip Mondal; Sunirmal Khatua; Zhumur Ghosh
Journal:  RNA Biol       Date:  2020-10-28       Impact factor: 4.652

9.  LncRNA HOTAIR promotes proliferation and inhibits apoptosis by sponging miR-214-3p in HPV16 positive cervical cancer cells.

Authors:  Yu Zhou; Yuqing Wang; Mingying Lin; Daiqian Wu; Min Zhao
Journal:  Cancer Cell Int       Date:  2021-07-28       Impact factor: 5.722

Review 10.  Chemoresistance Mediated by ceRNA Networks Associated With the PVT1 Locus.

Authors:  Olorunseun O Ogunwobi; Adithya Kumar
Journal:  Front Oncol       Date:  2019-08-27       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.